Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/30/1994 | EP0597964A4 Proliferation of hepatocyte precursors. |
11/30/1994 | EP0491733B1 Somatic embryogenesis of squash |
11/30/1994 | EP0383804B1 Generation of neural precursor cell lines |
11/30/1994 | EP0349578B1 Organism carrying a Single Chain Antibody Domain at its surface. |
11/30/1994 | CN1095759A In situ PCR amplification system |
11/30/1994 | CN1026795C Novel strain of yeast promoting speed of fermentation of saccharide, obtainment of same and application of same |
11/29/1994 | US5369028 Genetic engineering with cells |
11/29/1994 | US5369026 DNA encoding bovine coronavirus polypeptides E2 and E3 |
11/29/1994 | US5369025 Recombinant fowlpox vaccine for protection against Marek's disease |
11/29/1994 | US5369023 Method of purifying putrescine n-methyltransferase from tobacco plant extract with an anion exchange medium |
11/29/1994 | US5369021 Microorganism for selective production of a specific compound of avermectin and a method for selective production thereof |
11/29/1994 | US5369020 Method for suppressing coloring of human serum albumin |
11/29/1994 | US5369019 Genetic engineering |
11/29/1994 | US5369004 Five highly informative microsatellite repeat polymorphic DNA markers |
11/29/1994 | US5369003 Process for the specific production of ribonucleic acids |
11/29/1994 | US5368855 Pox virus vaccine |
11/29/1994 | CA2124272A1 Dna comprising plum pox virus and tomato spotted wilt virus cdna fragments for disease resistance |
11/29/1994 | CA2124027A1 Dna originating in a non-a non-b hepatitis virus gene and constituting polypeptide |
11/29/1994 | CA1333264C Radiolabeled anti-platelet monoclonal antibody for imaging in-vivo thrombi |
11/28/1994 | EP0663013A4 Method for delivering nucleic acids into cells. |
11/27/1994 | CA2124271A1 Process for preparing and purifying alpha-interferon |
11/26/1994 | CA2124171A1 Process for preparing 2-amino-3-hydroxy acids |
11/26/1994 | CA2124170A1 Process for preparing serine hydroxymethyltransferase |
11/24/1994 | WO1994027153A1 Methods of typing hepatitis c virus and reagents for use therein |
11/24/1994 | WO1994026934A2 Human papillomavirus detection assay |
11/24/1994 | WO1994026933A1 Genetic footprinting: insertional mutagenesis and genetic selection |
11/24/1994 | WO1994026931A1 Dyes designed for high sensitivity detection of double-stranded dna |
11/24/1994 | WO1994026925A2 Processes for producing an enzyme |
11/24/1994 | WO1994026924A3 MONOCLONAL ANTIBODIES AGAINST THE α-TNF TYPE I RECEPTOR, PROCESS FOR THE PRODUCTION AND USE THEREOF |
11/24/1994 | WO1994026924A2 MONOCLONAL ANTIBODIES AGAINST THE α-TNF TYPE I RECEPTOR, PROCESS FOR THE PRODUCTION AND USE THEREOF |
11/24/1994 | WO1994026923A1 Method for recombinant production of biologically active polypeptides |
11/24/1994 | WO1994026922A2 Methods and compositions relating to sterol regulatory element binding proteins |
11/24/1994 | WO1994026915A1 Gene transfer into pancreatic and biliary epithelial cells |
11/24/1994 | WO1994026914A1 Adenoviral vectors of animal origin and use thereof in gene therapy |
11/24/1994 | WO1994026913A2 Marker gene |
11/24/1994 | WO1994026912A1 Method and vector construct for increasing the expression of transgenes |
11/24/1994 | WO1994026911A1 A gene expression system utilizing an rna polymerase prebound to dna |
11/24/1994 | WO1994026910A1 Immunotoxins comprising gelonin and an antibody |
11/24/1994 | WO1994026909A1 Herbicide resistant plants |
11/24/1994 | WO1994026908A1 Cho cell sialidase by recombinant dna technology |
11/24/1994 | WO1994026907A1 Hippuricase gene |
11/24/1994 | WO1994026906A2 CLONED DNA ENCODING A UDP-GALNAc:POLYPEPTIDE,N-ACETYLGALACTOS AMINYLTRANSFERASE |
11/24/1994 | WO1994026905A1 Immortalized human cell lines containing exogenous cytochrome p450 genes |
11/24/1994 | WO1994026904A1 Hepatitis b virus mutants, reagents and methods for detection |
11/24/1994 | WO1994026903A2 Human influenza virus peptides binding hla-i molecule |
11/24/1994 | WO1994026902A1 Nucleic acids encoding human astrovirus serotype 2 and uses thereof |
11/24/1994 | WO1994026901A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
11/24/1994 | WO1994026900A2 Hybrid picornaviruses expressing chlamydial epitopes |
11/24/1994 | WO1994026899A1 Method for the culture in vitro of differents stages of tissue parasites |
11/24/1994 | WO1994026898A1 The synthesized gene encoding for trichosanthin protein |
11/24/1994 | WO1994026897A2 Dna encoding two fish neuropeptides |
11/24/1994 | WO1994026896A1 Increased expression of alpha-1-antitrypsin in expression vectors through the inclusion of intron ii |
11/24/1994 | WO1994026895A1 Human immunoglobulin vh gene and dna fragment containing the same |
11/24/1994 | WO1994026894A1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE |
11/24/1994 | WO1994026893A1 Bmp-10 compositions |
11/24/1994 | WO1994026892A1 Bmp-11 compositions |
11/24/1994 | WO1994026891A2 Purified mammalian flt3 ligands and agonists and antagonists thereof |
11/24/1994 | WO1994026890A1 Hiv-1 tar rna binding protein |
11/24/1994 | WO1994026889A2 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds |
11/24/1994 | WO1994026888A1 Inhibition of proliferation of vascular smooth muscle cell |
11/24/1994 | WO1994026887A1 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
11/24/1994 | WO1994026886A2 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
11/24/1994 | WO1994026885A1 Constitutive pseudohyphal growth yeast mutants |
11/24/1994 | WO1994026884A1 Embryonic stem cells for making chimeric and transgenic ungulates |
11/24/1994 | WO1994026882A1 Proline iminopeptidase, process for its preparation and its use in the flavouring of food compositions |
11/24/1994 | WO1994026879A1 CLONING AND EXPRESSION OF THE GENE OF THE MALOLACTIC ENZYME OF $i(LACTOCOCCUS LACTIS) |
11/24/1994 | WO1994026878A1 Expansins, proteins that catalyze plant cell wall expansion and weakening of paper fiber connections |
11/24/1994 | WO1994026877A1 Ribozyme gene therapy for hiv infection and aids |
11/24/1994 | WO1994026876A1 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer |
11/24/1994 | WO1994026873A1 Yeast strain and methods for expressing heterologous proteins in yeast |
11/24/1994 | WO1994026867A1 Direct lysis buffer and the detection of hiv-1 plasma viremia |
11/24/1994 | WO1994026787A1 Method for generating cell type specific phage antibody libraries |
11/24/1994 | WO1994026784A1 Composition of antibodies against hepatitis b surface antigen |
11/24/1994 | WO1994026782A1 PSEUDOMONAS SYRINGAE pv. SYRINGAE hrpZ GENE |
11/24/1994 | WO1994026781A1 Thermoresistant alpha-1-antitrypsin mutein |
11/24/1994 | WO1994026776A1 Therapeutic compounds |
11/24/1994 | WO1994026773A1 Regulation of antigen presentation |
11/24/1994 | WO1994026766A1 Dna polymerases with enhanced thermostability and enhanced length and efficiency of primer extension |
11/24/1994 | WO1994026312A1 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN inhA GENE |
11/24/1994 | WO1994026307A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
11/24/1994 | WO1994026306A1 Conserved motif of hepatitis c virus e2/ns1 region |
11/24/1994 | WO1994026305A1 Hiv immunogenic complexes |
11/24/1994 | WO1994026304A1 Otitis media vaccine |
11/24/1994 | WO1994026298A1 Methods for treating muscle diseases and disorders |
11/24/1994 | WO1994026290A1 Cytokine designated 4-1bb ligand and human receptor that binds thereto |
11/24/1994 | WO1994026106A1 Novel tracheal antimicrobial peptides |
11/24/1994 | WO1994026100A1 Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins |
11/24/1994 | WO1994026087A2 Recombinant protein production and insect cell culture and process |
11/24/1994 | WO1994023043A3 Control of plant abscission and pod dehiscence |
11/24/1994 | WO1994023035A3 Recombinant timothy grass pollen allergen phl p ii |
11/24/1994 | WO1994023034A3 Variant insulin-like growth factor I receptor subunits and methods for use thereof |
11/24/1994 | WO1994019472A3 Bi-functional expression system |
11/24/1994 | WO1994019466A3 A novel family of anti-carcinoembryonic antigen chimeric antibodies |
11/24/1994 | WO1994019464A3 Human dna sequence encoding a kidney atp-dependent potassium channel |
11/24/1994 | WO1994016101A3 Dna sequencing by mass spectrometry |
11/24/1994 | WO1994016073A3 Methods and reagents for inhibiting furin endoprotease |
11/24/1994 | WO1994015961A3 Synthetic amphipathic peptides with antimicrobial activity |
11/24/1994 | CA2500213A1 Gene transfer into pancreatic and biliary epithelial cells |
11/24/1994 | CA2165051A1 Dna encoding two fish neuropeptides |
11/24/1994 | CA2163234A1 Inhibition of proliferation of vascular smooth muscle cell |